Search

everythinglearnresearchcommunity

for

Search:↓

Only skin melanocytes, not other types, can color hair in mice.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

A man's gray hair got darker and thicker after using a psoriasis drug.

Researchers found genes that control hair color and growth change before the visible coat color changes in snowshoe hares.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

The document concludes that scalp conditions have various causes and can present in many different ways.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The new skin patch with human matrix and antibiotic improves wound healing.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.